Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Archives of Dermatological Research|February 1, 1997
Topical application of a first porphycene dye for photodynamic therapy--penetration studies in human perilesional skin and basal cell carcinomaS Karrer, C Abels, R M Szeimies, et al.
Klinische Padiatrie|November 9, 2010
Malignant melanoma and Wiedemann-Beckwith syndrome in childhoodE Livingstone, A Caliebe, F Egberts, et al.
Skin Pharmacology and Physiology|September 14, 2011
The impact of 10% α-hydroxy acid emulsion on skin pHS Schreml, R J Meier, M G Albert, et al.
Frontiers in Health Services|March 28, 2024
Integration of digital health applications into the German healthcare system: development of "The DiGA-Care Path"G D Giebel, C Abels, K Börchers, et al.
Frontiers in Health Services|May 13, 2024
Corrigendum: Integration of digital health applications into the German healthcare system: development of "The DiGA-Care Path"G D Giebel, C Abels, K Börchers, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1989
Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943AJ T Callis, C J Kuan, K R Branch, et al.
Journal of Photochemistry and Photobiology. B, Biology|April 1, 1997
Indocyanine green: intracellular uptake and phototherapeutic effects in vitroS Fickweiler, R M Szeimies, W Bäumler, et al.
The Journal of Investigative Dermatology|November 1, 1995
Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivoR M Szeimies, C Abels, C Fritsch, et al.
British Journal of Cancer|January 1, 1997
Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cellsH Messmann, M Geisler, U Gross, et al.
The British Journal of Dermatology|January 14, 2021
A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trialC Abels, M Soeberdt, A Kilic, et al.
Pageof 12